Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Vehicle for Bacterial Conjunctivitis (C-01-401-003)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female subject, of any race, who is at least 1 year of age.~* Subjects must have a clinical diagnosis of acute bacterial conjunctivitis and exhibit mucopurulent or purulent conjunctival discharge (crusty or sticky eyelids, globular and yellow discharge) and redness in at least one eye.~* The symptoms of bacterial conjunctivitis must be present for 3 days (approximately 72 hours) or less.~* Must be willing to discontinue contact lens wear for the duration of the study.~Exclusion Criteria:~* Any uncontrolled, systemic, debilitating disease.~* Use of topical ophthalmic solutions including tear substitutes within 2 hours before and during the study.~* Use of any topical ophthalmic anti-inflammatory agents within 48 hours before and during the study.~* Any active upper respiratory tract infection.~* Pregnant or nursing females.~* Use of any antibiotic (topical or systemic) within 72 hours of enrollment

- Gender: ALL
- Minimum Age: 12 Months
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- AzaSite (Type: EXPERIMENTAL): None
- Vehicle (Type: SHAM_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).